Oddity is branching into medical skincare with a new telehealth platform Methodiq, which blends the retailer's investments into biotech and computer vision.
The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s easier for Americans to access.